AML patient with organ dysfunction precluding intensive 7+3 induction: ECOG ≥3, baseline...
Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.
| ID | RF-AML-ORGAN-DYSFUNCTION |
|---|---|
| Type | Signal d’alerte |
| État | reviewed 2026-04-25 | pending_clinical_signoff |
| Maladies | DIS-AML |
| Sources | SRC-ELN-AML-2022 SRC-ESMO-AML-2020 SRC-NCCN-AML-2025 |
Origine du drapeau rouge
| Définition | AML patient with organ dysfunction precluding intensive 7+3 induction: ECOG ≥3, baseline LVEF <50%, CrCl <30 mL/min, total bilirubin >3× ULN, OR active uncontrolled organ failure |
|---|---|
| Direction clinique | désescalade |
| Catégorie | dysfonction d'organe |
| Algorithme de décalage | ALGO-AML-1L |
Logique de déclenchement
{
"any_of": [
{
"comparator": ">=",
"finding": "ecog_performance_status",
"threshold": 3
},
{
"comparator": "<",
"finding": "lvef_percent",
"threshold": 50
},
{
"comparator": "<",
"finding": "creatinine_clearance_ml_min",
"threshold": 30
},
{
"comparator": ">",
"finding": "total_bilirubin_ulnratio",
"threshold": 3
},
{
"finding": "active_uncontrolled_organ_failure",
"value": true
},
{
"finding": "transplant_eligible",
"value": false
}
],
"type": "composite"
}
Notes
Triggers de-escalation from 7+3 + (midostaurin) to ven+aza (VIALE-A) for unfit patients. Transplant-eligibility is a parallel layer also captured by this flag (organ thresholds are the same fitness gate). Cardiac assessment + baseline echo mandatory before anthracycline. STUB — requires clinical co-lead signoff before publication.
Utilisé par
Algorithmes
ALGO-AML-1L- ALGO-AML-1LALGO-AML-2L- ALGO-AML-2L
Indication
IND-AML-1L-7-3- IND-AML-1L-7-3IND-AML-1L-7-3-GO-CBF- IND-AML-1L-7-3-GO-CBFIND-AML-1L-CPX351-SECONDARY- IND-AML-1L-CPX351-SECONDARYIND-AML-1L-QUIZARTINIB-FLT3ITD- IND-AML-1L-QUIZARTINIB-FLT3ITDIND-AML-2L-GILTERITINIB-FLT3- IND-AML-2L-GILTERITINIB-FLT3IND-AML-2L-IDH2-ENASIDENIB- IND-AML-2L-IDH2-ENASIDENIBIND-AML-2L-KMT2A-REVUMENIB- IND-AML-2L-KMT2A-REVUMENIBIND-AML-CR1-ORAL-AZA-MAINTENANCE- IND-AML-CR1-ORAL-AZA-MAINTENANCEIND-AML-RR-IDH1-OLUTASIDENIB- IND-AML-RR-IDH1-OLUTASIDENIB